Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: September 2009
-
By Sydney Kokjohn — We recently received a dismissal of a Request for Reconsideration of Patent Term Adjustment Determination under 37 C.F.R. § 1.705(b). The Request was filed solely on the basis that the Patent Office had taken more than three years to issue the patent. The patent application was filed on December 7,…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. King Pharmaceuticals Inc. et al. v. Sandoz Inc.2:09-cv-04513; filed September 1, 2009 in the District Court of New Jersey • Plaintiffs: King…
-
September 13-15, 2009 – 2009 Annual Meeting (Intellectual Property Owners Association) – Chicago, IL September 14-15, 2009 – 3rd Summit on Biosimilars and Follow-on Biologics*** (Center for Business Intelligence) – National Harbor, MD September 15-16, 2009 – FDA Boot Camp*** (American Conference Institute) – Boston, MA September 17, 2009 – Developments in Pharmaceutical and Biotech…
-
By Donald Zuhn — In the August issue of Life Science Leader Magazine, Randal Kirk, Chairman and CEO of the venture capital firm Third Security, LLC, writes that while some 600 to 800 life science companies are expected to go out of business or be absorbed by other companies within the next two years,…
-
International Quality & Productivity Center (IQPC) will be holding its 5th Annual Developing IP Strategies for Crystalline Forms conference from November 9-11, 2009 in London, England. The conference will provide: • An international case law update for the EU, U.S., and India;• A judicial review presentation from Alastair Wilson QC, Joint Head of Chambers, Hogarth…
-
American Conference Institute (ACI) will be holding its 13th Advanced Forum on Structuring, Negotiating, and Managing Pharma/Biotech Collaborative Agreements from November 17-18, 2009 in New York, NY. The conference will allow attendees to: • Integrate emerging trends in investment capital and current deal structuring into product strategies;• Establish a strong presence in new and emerging…
-
By Donald Zuhn — A paper published in the latest issue of the policy journal Health Affairs disputes the widely held notion that the United States has eclipsed Europe in terms of pharmaceutical research productivity. In the article, entitled "Global Drug Discovery: Europe Is Ahead," Dr. Donald Light, a professor of social medicine in…
-
By Kevin E. Noonan — The fastest-growing part of the biotech/pharma industry is anticancer drugs, according to an article in The New York Times today ("For Profit, Industry Seeks Cancer Drugs"). Written by Andrew Pollack, one of the paper's senior business and technology writers, the article highlights the interplay between scientific interest and business…
-
By Suresh Pillai — Capricorn Keeps Zicam® IP Suit Active, But Loses Bid for Inventorship Change The U.S. District Court for the District of Delaware has ruled that Capricorn Pharma, Inc. can proceed with its suit against Matrixx Initiatives Inc. for allegedly infringing Capricorn's patent covering Zicam®, a cold medication. The patent-in-suit, U.S. Patent…
-
By Kevin E. Noonan — BioWorld Today posted an article last week about the top 25 biotech drugs currently on the market. Written by Michael Harris, Executive Editor, the piece represents a précis of a longer report by BioWorld, entitled "Market-Leading Biotechnology Drugs 2009: Blockbuster Dynamics in an Ailing Economy." In its brief overview,…
Patent Docs 